A small study funded by NIH has found that COVID-19 antigen testing and PCR tests are equally effective in detecting SARS-CoV-2 infection when used for serial screening conducted every three days. The results are good news for antigen test makers such as Abbott, Becton Dickinson and Quidel. Source: Medtechdive
